Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
机构:
Liverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, EnglandLiverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, England
Magapu, Pradeep
Haskard, Dorian
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Vasc Sci Sect, London, EnglandLiverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, England
Haskard, Dorian
Fisher, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Liverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, EnglandLiverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, England
机构:
Tan Tock Seng Hosp, Dept Cardiol, Singapore 308433, SingaporeTan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore
Ho, H. H.
Lau, T. W.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China
Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R ChinaTan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore
Lau, T. W.
Leung, F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R ChinaTan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore
Leung, F.
Tse, H-F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China
Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R ChinaTan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore
Tse, H-F.
Siu, C-W.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China
Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R ChinaTan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore